Once something is covered by Medicare, she said it can be difficult to not cover it in other areas
For patients unable to access either medication through prescription channels, compounded tirzepatide is more readily available than mazdutide
In a phase 2b trial, tirzepatide treatment was associated in a dose-dependent manner with decreased levels of apolipoprotein (apo) B, apoC-III, large triglyceride-rich lipoprotein particles, and small low-density lipoprotein particles, suggesting a shift towards a less atherogenic lipoprotein profile [77]
Worth noting: there's no soluble/insoluble fiber breakdown on the label, which makes it harder to evaluate how much of that 4g is doing the GLP-1-relevant work
The biggest price shift comes from the access pathway Retatrutide is still investigational, so the U.S